Everyone feels a bit sad or lonely from time to time. It’s only natural. Particularly in the wake of a significant loss, a setback at work or another of life’s curveballs. But there’s a difference between grieving the loss of a loved one, the breakup of a relationship or a professional setback and depression. In …
There is a very real concern in the United States that doctors are overprescribing antidepressant medications to their patients. AARP mentions that prescribing meds “without a diagnosis of depression is escalating” especially among the elderly population. Most often, medications are prescribed by a primary care physician or a psychiatrist for depression and mood disorders. Common …
What is Ketamine? Ketamine, also known as Ketalar, Ketaset, and Ketanest, is a medication that’s currently FDA approved only as an anesthetic but it’s showing great potential as a treatment for severe depression. In fact, numerous Ketamine Clinics have begun to appear throughout the United States to solve this problem. Depressed patients with stubborn symptoms get relief …
An experimental drug touted as a breakthrough for treating severe postpartum depression is showing some promising results in a small clinical trial. Sage Therapeutics (SAGE), based in Cambridge, Mass., reported on Tuesday that 7 of the 10 women who took the drug in the trial experienced significant improvement in their depression within 60 hours of …
Key Findings Approximately 6-7% of full-time U.S. workers experienced major depression (MDD) within the past year. The total economic burden of MDD is now estimated to be $210.5 billion per year. For every dollar spent on MDD direct costs in 2010, an additional $1.90 was spent on MDD-related indirect costs. An important study reveals just …
On March 5, 2019 the Food and Drug Administration (FDA) approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made waves for its surprising antidepressant effect. Interestingly, studies from Yale research labs showed that the drug ketamine, which was widely used as …
At last count, about 12% of Americans took antidepressants. Global revenue for antidepressants was about $14.5 billion in 2014 and is projected to grow to nearly $17 billion over the next three years. Clinical depression affects 6.7% of U.S. adults, or about 16 million people, and a growing number of children and teenagers too. It’s …
If you keep up with the news then chances are, you have heard about the exciting recent discoveries that have been made when it comes to ketamine therapy. This is one of those rare instances in which you should actually investigate the hype. Those who suffer from depression know how devastating and isolating it can …
Depression is a condition that is poorly understood by the public. Major depressive disorder is widespread, one of the most prevalent mental health issues in this country. It affects an estimated 17.3 million residents including 8.7 percent of adult women and 5.3 percent of adult men. There is a stigmatism attached to depression that can keep …
One in seven new mothers experience some degree of postpartum depression, preventing them from fully engaging in this wonderful time. Explore how TMS therapy is helping scores of women enjoy motherhood without resorting to medications. The first year of motherhood has its challenges under the best of circumstances. If you’re struggling with postpartum depression, however, …
Bespoke Treatment focuses on non-medication treatments that work. We are the first boutique center in Southern California to specialize in personalized TMS therapy, Ketamine treatment, and psychiatry.
